doi: 10.1016/j.freeradbiomed.2008.05.003 135 GubernCCamsSBallesterosIRodrguezRRomeraVGCaadasRet al
Portillo Canales and colleagues tracked 110 men with obesity - many also with type 2 diabetes - who were being treated with semaglutide, dulaglutide or tirzepatide, the active ingredients in Novo Nordisk's Wegovy and Ozempic or Eli Lilly's Trulicity, Mounjaro, and Zepbound
Free-text responses indicated providers wanted further guidance from the ASA, as current guidelines may be insufficient regarding the NPO as well as medication cessation recommendations, the article states
This weeks column is by the UK College of Pharmacy Chief Practice Officer Brooke Hudspeth, Pharm.D
Once approved, your prescription is sent to the pharmacy and prepared for discreet pickup or delivery so you can start your program without delay
If you are experiencing sexual side effects without corresponding weight loss benefits, this is an important conversation to have with your provider